obesity

Diabetes And Obesity Options Percolate At JNJ, Novo
Forbes
Wed, 06/23/10 - 09:07 am
obesity
Novo Nordisk
diabetes
JNJ
Ortho-McNeil-Janssen
Data From EnteroMedics' VBLOC-DM2 ENABLE Study to Be Presented at American Society for Metabolic and Bariatric Surgery Meeting
Tue, 06/22/10 - 12:10 pm
EnteroMedics
Vbloc
Maestro System
obesity
Empower Study
vagal blocking therapy
Novo to restart obesity research on Victoza
Fierce Pharma
Tue, 06/22/10 - 11:21 am
Novo Nordisk
Victoza
obesity
Weight-loss surgery urged for obese kids may boost Allergan
Mon, 06/21/10 - 10:51 am
weight-loss surgery
gastric band
Allergan
obesity
Orexigen says FDA sets Jan. 31 date for Contrave
Yahoo/AP
Thu, 06/17/10 - 11:03 pm
FDA
Contrave
Orexigen
obesity
Will the Obesity Epidemic Spur a New ED Pill Just for Diabetics? One Drug Company Seems to Think So
BNET Pharma
Wed, 06/9/10 - 09:15 am
Vivus
obesity
diabetes
Avanafil
erectile dysfunction
FDA Panel for Arena Obesity Drug
Yahoo/Zacks.com
Thu, 06/3/10 - 08:54 pm
Arena Pharmaceuticals
obesity
FDA
advisory panels
Is Arena’s Lorcaserin More Valuable Than Dendreon’s Provenge?
Seeking Alpha
Fri, 05/14/10 - 08:33 am
Arena Pharmaceuticals
lorcaserin
Dendreon
obesity
Provenge
GI Dynamics touts more clinical trials data
Mon, 05/3/10 - 11:42 am
GI Dynamics
EndoBarrier
type 2 diabetes
obesity
Orexigen revises obesity drug data; shares fall
Reuters
Wed, 04/14/10 - 10:44 am
obesity
Orexigen
Contrave
New Obesity Pills: The Pipeline Getting Fat?
CNBC
Tue, 04/13/10 - 09:42 am
obesity
Vivus
Qnexa
Arena Pharmaceuticals
Orexigen
Contrave
Orexigen asks FDA for weight-loss drug approval
Yahoo/AP
Wed, 03/31/10 - 09:51 pm
Orexigen
FDA
obesity
Contrave
Vivus
Arena Pharmaceuticals
Qnexa
FDA to Review VIVUS Drug
Yahoo/Zacks.com
Mon, 03/29/10 - 11:23 am
FDA
obesity
Vivus
Orexigen
Arena Pharmaceuticals
Qnexa
Amylin
Bulls Anticipating a Vivus Upside
Seeking Alpha
Sat, 03/27/10 - 11:15 am
Vivus
obesity
Qnexa
Rise in obesity makes VCs hungry for startups
Reuters
Fri, 03/26/10 - 09:10 am
venture capital
obesity
Rhythm Pharmaceuticals
Elixir Medical
FDA panel to review Vivus drug in July
Fierce Biotech
Fri, 03/26/10 - 09:09 am
Vivus
FDA
obesity
Qnexa
3 Ways to Play the Obesity Drugs
TheStreet.com
Tue, 03/16/10 - 10:05 am
obesity
Arena Pharmaceuticals
Vivus
Orexigen
Contrave
Qnexa
lorcaserin
EnteroMedics retools, refocuses to win FDA approval
Med City News
Sat, 03/13/10 - 10:55 am
EnteroMedics
obesity
Maestro
Arena will launch lorcaserin with partner or alone
Reuters
Fri, 03/12/10 - 09:36 am
Arena Pharmaceuticals
obesity
lorcaserin
FDA accepts Vivus application for obesity drug
Marketwatch
Mon, 03/1/10 - 09:57 am
FDA
Vivus
obesity
Qnexa

Pages